Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy

NCT06717412 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Retinopathy of Prematurity (ROP)

Interventions

DRUG: Conbercept

Sponsor

Wang Yusheng